Developer docs
API playgroundTry for free, no card

Search company profiles

Spencer Trask & Co

Full company profile

uuid0008q2h

Namestring
Spencer Trask & Co
Legal namestring
Spencer Trask & Co.
Company typeenum
Private
Founded yearint
1860
Descriptiontext

Spencer Trask & Co. is a privately held advanced technology development firm headquartered in Greenwich, Connecticut, that operates as both a venture creator and early-stage investor. The modern firm was re-established under Chairman Kevin Kimberlin and traces its institutional lineage to the original Spencer Trask, who financed Thomas Edison, founded the world's first electric power company, purchased The New York Times in 1896, and underwrote the Marconi Wireless Telegraph Company and Moody's statistical services. Under its contemporary identity, Spencer Trask co-founds or first-funds transformative technology companies at the conception phase and provides capital, strategic guidance, and operational support through to exit. Its portfolio spans healthcare and biotech (Myriad Genetics, Immune Response Corporation with Jonas Salk, Osiris Therapeutics, Health Dialog, Vesselon, Good Measures), technology infrastructure (Ciena, DFMsim now in Applied Materials' AiX platform), legal technology (Fastcase, merged into vLex), supply chain AI (Interos.ai), and financial technology (SeedInvest, which merged into Circle/USDC). The firm states that it co-founded or first-funded twelve startups that each reached valuations exceeding $1 billion, that its portfolio companies have raised more than $5 billion from strategic and institutional partners, and that those companies have created over 100,000 jobs.

Economically, Spencer Trask generates revenue through portfolio exit proceeds (capital appreciation from acquisitions and IPOs) and strategic advisory and development services for its portfolio companies. The firm does not publicly disclose pricing, fund size, AUM, or revenue; its management team is small (11-50 employees) and concentrated, led by Chairman Kevin Kimberlin, CEO emeritus William Clifford (formerly CEO of Gartner Group), Managing Directors Paul Latchford and Neil Edwards, Chief of Staff Kerry Safir, Chief Communications Officer Jamie Dunne, and Chief Technology Officer Ron Buesing. Notable recent exits include Health Dialog (acquired for $775 million by BUPA), the vLex-Fastcase combination (acquired by Clio for $1 billion in July 2025), Good Measures (acquired by NationsBenefits in November 2024), and Circle Internet Financial (NYSE IPO in June 2025 following USDC's $25 trillion+ in on-chain transactions). The firm's stated philosophy centers on a "double bottom line" — pursuing both net worth (financial return) and net worthiness (societal impact) — and it cultivates a network of more than 38 strategic, institutional, and corporate partners including BlackRock, Fidelity, Bain Capital, Kleiner Perkins, Venrock, Goldman Sachs, Accenture, and major pharmaceutical companies.

Short descriptiontext

Spencer Trask & Co. is a privately held Greenwich, Connecticut-based advanced technology development firm that co-founds and first-funds transformative ventures in healthcare, AI, semiconductors, legal technology, and financial technology from conception through exit. The firm has produced 12 unicorns, $5B+ in portfolio capital raised, and recent exits including Clio's $1B vLex-Fastcase acquisition and Circle's 2025 NYSE IPO.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersGreenwich, United States
HQ citystring
Greenwich
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
venture capital, private equity, technology incubation, venture development, growth capital
Product category
Private Equity and Venture Capital
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Investment Returns / Portfolio Exit Revenue
TypeLicensing Royalties
Description

The firm generates returns through successful exits of portfolio companies. Examples include Health Dialog ($770M acquisition), Fastcase-vLex ($1B acquisition by Clio), SeedInvest (acquired by Circle which went public), and various other venture investments. The firm's revenue is derived from capital appreciation and exit proceeds from transformative technology companies they help build.

spencertraskco.com
2Strategic Advisory and Development Services
TypeProfessional Services
Description

The firm provides advanced technology development services, helping entrepreneurs transform concepts into world-leading ventures. This includes strategic guidance, operational support, and access to their network of investors and partners.

spencertraskco.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components3 values
Personnel, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Spencer Trask & Co. is an advanced technology development firm that discovers bright ideas and helps brilliant entrepreneurs turn them into world-changing ventures. The firm provides capital, strategic guidance, and operational support during the conception phase, focusing on transformative companies across healthcare/biotech, AI, genomics, telecommunications, semiconductor, legal technology, and digital currency sectors.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 12 startups each grew to valuations exceeding $1 billion
+4 more records
Product overview1 text field

Spencer Trask & Co. is an advanced technology development firm that discovers and builds transformative technology ventures. Rather than a single product, they operate a portfolio of technology companies across multiple sectors: healthcare (Good Measures, Health Dialog, Immune Response, Osiris Therapeutics, Myriad Genetics, Vesselon), technology infrastructure (Ciena, DFMsim/AiX, Interos.ai), legal technology (Fastcase/vLex), and financial technology (SeedInvest, Circle/USDC). The firm takes a hands-on approach, providing leadership, capital, and strategic guidance from venture conception through exit. Their portfolio has generated 12 unicorns ($1B+ valuations) and received over $5 billion in investments. The companies work across AI-powered platforms for personalized nutrition, legal research, supply chain monitoring, genomics, stem cell therapy, drug delivery, and digital currency.

Product and service3 records
1Venture Capital Investment
CategoryVenture Capital
Description

Provides capital investment in transformative technology ventures during the conception and growth phases, targeting startups across healthcare, AI, telecommunications, legal technology, and digital currency.

2Strategic Advisory Services
CategoryAdvisory Services
Description

Provides strategic guidance, operational support, and access to a network of strategic, institutional, and corporate investors to entrepreneurs during the fragile conception phase of venture development.

3Venture Development Services
CategoryVenture Development
Description

Hands-on venture development and incubation services that transform concepts into tangible products, services, and world-leading ventures, applying a 'double bottom line' approach of Net Worth and Net Worthiness.

Scale indicator13 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierMajorTypeStrategic or Co-development Partner
Description

NationsBenefits acquired Spencer Trask venture Good Measures in November 2024. NationsBenefits serves over 100 health plans and delivers 25 million meals annually, creating the first nationally scaled Food as Medicine platform.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

SeedInvest (Spencer Trask portfolio) merged into Circle at USDC launch. Circle conducted IPO in June 2025. Spencer Trask is first investor in Circle/USDC stablecoin.

3Clio
Strategic tierMajorTypeStrategic or Co-development Partner
Description

Clio acquired vLex-Fastcase (Spencer Trask portfolio company) for $1 billion in June 2025. Clio is the leading cloud practice-management platform used by more than 200,000 law firms.

spencertraskco.com
Strategic tierMajorTypeStrategic or Co-development Partner
Description

vLex merged with Spencer Trask portfolio company Fastcase in 2023, creating the world's largest AI-enabled legal research platform serving 3.8 million users across 100+ countries.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

Interos acquired Spencer Trask's AI platform (Trensant AI) and reached unicorn status with $300M+ raised from Accenture, Venrock, Knight Dragon, Kleiner Perkins, Coupa, Blue Owl, and others. Interos tracks 350 million entities and 18 billion business relationships.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Venture creation firm that originates and builds biotech and platform companies from novel scientific concepts, mirroring Spencer Trask's conception-phase model of co-founding transformative ventures in healthcare and life sciences.

TypeDirect peer
Description

Early-stage venture firm focused on founding and seeding breakthrough science and technology companies, comparable to Spencer Trask's model of backing first-in-category companies in biotech, AI, and deep tech.

TypeDirect peer
Description

Frontier-technology venture firm investing at the intersection of science, technology, and innovation, closely aligned with Spencer Trask's portfolio mix of AI infrastructure, semiconductors, and life sciences.

TypeDirect peer
Description

Early-stage venture firm with a high-conviction, founder-first approach to technology, healthcare, and sustainability, comparable to Spencer Trask's willingness to back transformative, science-led companies at the idea stage.

TypeDirect peer
Description

Early-stage venture firm investing in transformative technologies across healthcare, fintech, and frontier tech, with a similar thesis of backing bold, world-changing companies at the conception phase.

TypeBroad incumbent
Description

Large-scale venture firm with broad sector coverage across bio/health, AI, fintech, and crypto, overlapping with several of Spencer Trask's portfolio themes (USDC/stablecoins, legal tech, healthcare) but with much greater scale and resources.

TypeBroad incumbent
Description

Historic venture firm investing across technology, healthcare, and consumer, including a co-investment relationship with Spencer Trask portfolio company Interos; comparable in cross-sector transformative-tech focus.

TypeBroad incumbent
Description

Long-tenured venture firm with deep technology and healthcare roots that has co-invested with Spencer Trask in Interos, sharing a thesis of early identification of category-defining technology companies.

TypeBroad incumbent
Description

Global venture firm with strong healthcare and technology franchises, comparable to Spencer Trask's emphasis on transformative science and technology investments at the earliest stages.

TypeOthers
Description

Strategic not-for-profit investor that identifies and funds early-stage technologies with national-security and mission impact, thematically similar to Spencer Trask's emphasis on transformative, mission-driven technology bets.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration1 record

Each record includes

Title, Type, Description, Source

AI capability12 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment15 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Spencer Trask & Co

Private Equity and Venture Capitalspencertraskco.com

Spencer Trask & Co. is a privately held Greenwich, Connecticut-based advanced technology development firm that co-founds and first-funds transformative ventures in healthcare, AI, semiconductors, legal technology, and financial technology from conception through exit. The firm has produced 12 unicorns, $5B+ in portfolio capital raised, and recent exits including Clio's $1B vLex-Fastcase acquisition and Circle's 2025 NYSE IPO.

What Spencer Trask & Co does

Spencer Trask & Co. is a privately held advanced technology development firm headquartered in Greenwich, Connecticut, that operates as both a venture creator and early-stage investor. The modern firm was re-established under Chairman Kevin Kimberlin and traces its institutional lineage to the original Spencer Trask, who financed Thomas Edison, founded the world's first electric power company, purchased The New York Times in 1896, and underwrote the Marconi Wireless Telegraph Company and Moody's statistical services. Under its contemporary identity, Spencer Trask co-founds or first-funds transformative technology companies at the conception phase and provides capital, strategic guidance, and operational support through to exit. Its portfolio spans healthcare and biotech (Myriad Genetics, Immune Response Corporation with Jonas Salk, Osiris Therapeutics, Health Dialog, Vesselon, Good Measures), technology infrastructure (Ciena, DFMsim now in Applied Materials' AiX platform), legal technology (Fastcase, merged into vLex), supply chain AI (Interos.ai), and financial technology (SeedInvest, which merged into Circle/USDC). The firm states that it co-founded or first-funded twelve startups that each reached valuations exceeding $1 billion, that its portfolio companies have raised more than $5 billion from strategic and institutional partners, and that those companies have created over 100,000 jobs.

Economically, Spencer Trask generates revenue through portfolio exit proceeds (capital appreciation from acquisitions and IPOs) and strategic advisory and development services for its portfolio companies. The firm does not publicly disclose pricing, fund size, AUM, or revenue; its management team is small (11-50 employees) and concentrated, led by Chairman Kevin Kimberlin, CEO emeritus William Clifford (formerly CEO of Gartner Group), Managing Directors Paul Latchford and Neil Edwards, Chief of Staff Kerry Safir, Chief Communications Officer Jamie Dunne, and Chief Technology Officer Ron Buesing. Notable recent exits include Health Dialog (acquired for $775 million by BUPA), the vLex-Fastcase combination (acquired by Clio for $1 billion in July 2025), Good Measures (acquired by NationsBenefits in November 2024), and Circle Internet Financial (NYSE IPO in June 2025 following USDC's $25 trillion+ in on-chain transactions). The firm's stated philosophy centers on a "double bottom line" — pursuing both net worth (financial return) and net worthiness (societal impact) — and it cultivates a network of more than 38 strategic, institutional, and corporate partners including BlackRock, Fidelity, Bain Capital, Kleiner Perkins, Venrock, Goldman Sachs, Accenture, and major pharmaceutical companies.

Spencer Trask & Co firmographics

Firmographics
Name
Spencer Trask & Co
Legal name
Spencer Trask & Co.
Website
https://spencertraskco.com
Company type
Private
Founded year
1860
Operating status
Operating
Headcount range
11–50 employees
Short description
Spencer Trask & Co. is a privately held Greenwich, Connecticut-based advanced technology development firm that co-founds and first-funds transformative ventures in healthcare, AI, semiconductors, legal technology, and financial technology from conception through exit. The firm has produced 12 unicorns, $5B+ in portfolio capital raised, and recent exits including Clio's $1B vLex-Fastcase acquisition and Circle's 2025 NYSE IPO.
Ownership category
akta.pro rank

Where Spencer Trask & Co is headquartered

Location

Headquarters

HQ city
Greenwich
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Spencer Trask & Co business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales

Revenue model

  1. Investment Returns / Portfolio Exit Revenue: The firm generates returns through successful exits of portfolio companies. Examples include Health Dialog ($770M acquisition), Fastcase-vLex ($1B acquisition by Clio), SeedInvest (acquired by Circle which went public), and various other venture investments. The firm's revenue is derived from capital appreciation and exit proceeds from transformative technology companies they help build.
  2. Strategic Advisory and Development Services: The firm provides advanced technology development services, helping entrepreneurs transform concepts into world-leading ventures. This includes strategic guidance, operational support, and access to their network of investors and partners.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Spencer Trask & Co product offering

Product offering

Core offering

Spencer Trask & Co. is an advanced technology development firm that discovers bright ideas and helps brilliant entrepreneurs turn them into world-changing ventures. The firm provides capital, strategic guidance, and operational support during the conception phase, focusing on transformative companies across healthcare/biotech, AI, genomics, telecommunications, semiconductor, legal technology, and digital currency sectors.

Product overview

Spencer Trask & Co. is an advanced technology development firm that discovers and builds transformative technology ventures. Rather than a single product, they operate a portfolio of technology companies across multiple sectors: healthcare (Good Measures, Health Dialog, Immune Response, Osiris Therapeutics, Myriad Genetics, Vesselon), technology infrastructure (Ciena, DFMsim/AiX, Interos.ai), legal technology (Fastcase/vLex), and financial technology (SeedInvest, Circle/USDC). The firm takes a hands-on approach, providing leadership, capital, and strategic guidance from venture conception through exit. Their portfolio has generated 12 unicorns ($1B+ valuations) and received over $5 billion in investments. The companies work across AI-powered platforms for personalized nutrition, legal research, supply chain monitoring, genomics, stem cell therapy, drug delivery, and digital currency.

Differentiator

Problem solved

Functional benefit

Products and services

  • Venture Capital Investment Provides capital investment in transformative technology ventures during the conception and growth phases, targeting startups across healthcare, AI, telecommunications, legal technology, and digital currency.
  • Strategic Advisory Services Provides strategic guidance, operational support, and access to a network of strategic, institutional, and corporate investors to entrepreneurs during the fragile conception phase of venture development.
  • Venture Development Services Hands-on venture development and incubation services that transform concepts into tangible products, services, and world-leading ventures, applying a 'double bottom line' approach of Net Worth and Net Worthiness.

Quantifiable outcome

  • 12 startups each grew to valuations exceeding $1 billion
  • +4 more outcomes

Companies that use Spencer Trask & Co

Customer profile

Named customers5 records

Segments2 records

Ideal customer profiles2 records

Spencer Trask & Co technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability12 records

Spencer Trask & Co partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered major.

  • NationsBenefitsmajorStrategic or Co-development PartnerNationsBenefits acquired Spencer Trask venture Good Measures in November 2024. NationsBenefits serves over 100 health plans and delivers 25 million meals annually, creating the first nationally scaled Food as Medicine platform.
  • Circle Internet FinancialmajorStrategic or Co-development PartnerSeedInvest (Spencer Trask portfolio) merged into Circle at USDC launch. Circle conducted IPO in June 2025. Spencer Trask is first investor in Circle/USDC stablecoin.
  • CliomajorStrategic or Co-development PartnerClio acquired vLex-Fastcase (Spencer Trask portfolio company) for $1 billion in June 2025. Clio is the leading cloud practice-management platform used by more than 200,000 law firms.
  • vLexmajorStrategic or Co-development PartnervLex merged with Spencer Trask portfolio company Fastcase in 2023, creating the world's largest AI-enabled legal research platform serving 3.8 million users across 100+ countries.
  • InterosmajorStrategic or Co-development PartnerInteros acquired Spencer Trask's AI platform (Trensant AI) and reached unicorn status with $300M+ raised from Accenture, Venrock, Knight Dragon, Kleiner Perkins, Coupa, Blue Owl, and others. Interos tracks 350 million entities and 18 billion business relationships.

Scale indicators13 records

Recent moves6 records

Expansion highlights5 records

Spencer Trask & Co competitors and assessment

Company assessment

Direct peers

  • Flagship Pioneering: Venture creation firm that originates and builds biotech and platform companies from novel scientific concepts, mirroring Spencer Trask's conception-phase model of co-founding transformative ventures in healthcare and life sciences.
  • ARCH Venture Partners: Early-stage venture firm focused on founding and seeding breakthrough science and technology companies, comparable to Spencer Trask's model of backing first-in-category companies in biotech, AI, and deep tech.
  • Lux Capital: Frontier-technology venture firm investing at the intersection of science, technology, and innovation, closely aligned with Spencer Trask's portfolio mix of AI infrastructure, semiconductors, and life sciences.
  • Khosla Ventures: Early-stage venture firm with a high-conviction, founder-first approach to technology, healthcare, and sustainability, comparable to Spencer Trask's willingness to back transformative, science-led companies at the idea stage.
  • Founders Fund: Early-stage venture firm investing in transformative technologies across healthcare, fintech, and frontier tech, with a similar thesis of backing bold, world-changing companies at the conception phase.

Broad incumbents

  • Andreessen Horowitz (a16z): Large-scale venture firm with broad sector coverage across bio/health, AI, fintech, and crypto, overlapping with several of Spencer Trask's portfolio themes (USDC/stablecoins, legal tech, healthcare) but with much greater scale and resources.
  • Kleiner Perkins: Historic venture firm investing across technology, healthcare, and consumer, including a co-investment relationship with Spencer Trask portfolio company Interos; comparable in cross-sector transformative-tech focus.
  • Venrock: Long-tenured venture firm with deep technology and healthcare roots that has co-invested with Spencer Trask in Interos, sharing a thesis of early identification of category-defining technology companies.
  • General Catalyst: Global venture firm with strong healthcare and technology franchises, comparable to Spencer Trask's emphasis on transformative science and technology investments at the earliest stages.

Others

  • In-Q-Tel: Strategic not-for-profit investor that identifies and funds early-stage technologies with national-security and mission impact, thematically similar to Spencer Trask's emphasis on transformative, mission-driven technology bets.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Spencer Trask & Co social profiles

Digital presence

Spencer Trask & Co financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Spencer Trask & Co leadership team

Management profile

Number of profiles

Profiles7 records

Spencer Trask & Co funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Spencer Trask & Co M&A and investment

M&A and investment

M&A

Investments15 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Spencer Trask & Co

What does Spencer Trask & Co do?

Spencer Trask & Co. is an advanced technology development firm that discovers bright ideas and helps brilliant entrepreneurs turn them into world-changing ventures. The firm provides capital, strategic guidance, and operational support during the conception phase, focusing on transformative companies across healthcare/biotech, AI, genomics, telecommunications, semiconductor, legal technology, and digital currency sectors.

Is Spencer Trask & Co a public or private company?

Spencer Trask & Co is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Spencer Trask & Co founded?

Spencer Trask & Co was founded in 1860. It employs 11 to 50 people.

Where is Spencer Trask & Co based?

Spencer Trask & Co is headquartered in Greenwich, United States, in the North America region.

How does Spencer Trask & Co make money?

Two revenue lines are on record. Investment Returns / Portfolio Exit Revenue is the primary driver. The others are strategic Advisory and Development Services.

Who are Spencer Trask & Co's main competitors?

Direct peers on record are Flagship Pioneering, ARCH Venture Partners, Lux Capital, Khosla Ventures and Founders Fund. Broad incumbents are Andreessen Horowitz (a16z), Kleiner Perkins, Venrock and General Catalyst. In-Q-Tel is listed as an others.

Does Spencer Trask & Co have an API?

No public API is recorded for Spencer Trask & Co.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
AiThoritySupply Chain Unicorn Built on Spencer Trask & Co. AI VentureInteros, a female-led operational resilience firm, closed a $100 million Series C funding round led by NightDragon with Kleiner Perkins and Venrock. The firm, built on Spencer Trask & Co. venture Trensant, has raised $125 million in venture capital and scaled to help government and Fortune 500 businesses maintain operational resilience.PR NewswireSupply Chain Unicorn Built on Spencer Trask & Co. AI VentureSupply chain risk monitoring firm Interos, a female-led unicorn, closed a $100 million Series C funding round led by NightDragon with participation from Kleiner Perkins and Venrock, following a 2018 merger with Trensant, Inc. that incorporated Trensant's AI engine—built on principles of chaos physics by co-founder Dr. Minh Duong-van—into Interos' supply chain risk monitoring platform. The funding marks the 12th venture co-founded or first-funded by Spencer Trask & Co. to reach a $1 billion valuation, with Spencer Trask & Co. Chairman Kevin Kimberlin noting that 2020 represented a seismic shift in world economic order due to supply chain disruptions.PR NewswireSpencer Trask & Co. Partners with UCLA Samueli School of Engineering to Support 50th Anniversary of the Internet CelebrationSpencer Trask & Co., a privately held advanced technology development firm, announced a partnership with UCLA Samueli School of Engineering to support the 50th anniversary of the Internet celebration on October 29, 2019 at UCLA's Royce Hall. The event, titled 'Internet50: Founders and Futurists,' was organized by UCLA computer science professor Leonard Kleinrock, a foundational figure in Internet development, and featured keynote remarks from Spencer Trask Chairman Kevin Kimberlin reflecting on the history of Internet innovation. The partnership highlights Spencer Trask's ongoing involvement in supporting technology ventures and entrepreneurship in the technology sector.PR NewswireSpencer Trask Announces Global Crowdsourcing Program for Eradication of Polio in PakistanSpencer Trask & Co. has partnered with Rotary International and the World Health Organization (WHO) to launch a global crowdsourcing challenge via InnoCentive, offering $10,000 each to up to three winning solutions that combat online misinformation about polio vaccination in Pakistan. The initiative responds to a reported 200% increase in internet usage in Pakistan since 2012, which has fueled the spread of anti-vaccine rumors as the country struggles to eradicate polio—one of only two nations still reporting wild poliovirus cases. Pakistan has seen polio cases rise from 8 in 2017 to 62 new cases reported in 2019.PR NewswireSpencer Trask & Co. Backed Venture Ultra Capital LLC Accepts New CapitalizationSpencer Trask & Co.-backed venture Ultra Capital LLC has accepted new investment from Philadelphia-based LL Funds, making LL Funds the anchor equity investor in Ultra's next multi-hundred million dollar fund. The new capitalization will allow LL Funds and other institutional investors to participate in Ultra's $1.2 billion pipeline of sustainable infrastructure projects in agriculture, energy, waste, and water sectors. Kevin Kimberlin, Chairman of Spencer Trask & Co. and founding member of Ultra Capital, stated that Ultra was established to prove that financially prudent sustainability can be a winning combination.PR NewswireCrowdfunding Firm Funded by Spencer Trask & Co. Acquired by CircleSeedInvest, an equity crowdfunding firm that has helped fund more than 220 new ventures through its network of over 240,000 investors, was acquired by Circle Internet Financial Ltd., a global crypto finance company valued at $2.8 billion. Spencer Trask & Co., which was a major investor in SeedInvest through its Series A round, becomes a new stakeholder in Circle as part of the transaction. The acquisition is intended to enable SeedInvest to expand into private security markets using tokens, virtual currencies, and blockchain technology, with Circle's global reach and relationships.PR NewswireSpencer Trask & Co. and its Affiliated Investors Close the Sale of ImThera Medical, Inc.Spencer Trask & Co. and its affiliated investors completed the sale of ImThera Medical, Inc. to LivaNova PLC in a transaction valued at approximately $225 million. ImThera, a privately owned company headquartered in San Diego, has developed a neurostimulation therapy for obstructive sleep apnea that received European CE mark approval in 2012 and is currently completing a 141-patient Phase III clinical trial in the United States. LivaNova, a London-headquartered global medical technology company with operations across Italy, France, and the United States, acquired ImThera to expand its neuromodulation portfolio.PR NewswireSpencer Trask & Co Chairman Kevin Kimberlin Gives Presentation on the Origin of First Pocket Sized Cell PhoneSpencer Trask Chairman Kevin Kimberlin presented on the origin of the first pocket-sized cell phone at Mobile World Congress Americas in San Francisco. He detailed his work with Millicom and Jan Stenbeck, noting that only about 8% of the world had a landline in 1982, making the cell phone a need for the rest of the world.PR NewswireSpencer Trask Joins UNICEF and the Bill & Melinda Gates Foundation to Support 5th Annual World Polio DaySpencer Trask & Co. announced its sponsorship of the 5th Annual World Polio Day on October 24, 2017, joining UNICEF and the Bill & Melinda Gates Foundation as sponsors for the event hosted by Rotary International. Rotary has contributed more than $1 billion toward polio eradication, with funds matched 2:1 by the Gates Foundation. Spencer Trask & Co. Chairman Kevin Kimberlin has supported polio eradication efforts since partnering with Dr. Jonas Salk in 1986.